Search Ontology:
ChEBI
beta-D-Galp-(1->4)-alpha-D-GalpNAc-(1->3)-[alpha-L-Fucp-(1->2)]-beta-D-Galp-(1->4)-beta-D-GlcpNAc
- Term ID
- CHEBI:70841
- Synonyms
-
- 6-deoxy-alpha-L-galactopyranosyl-(1->2)-[beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-alpha-D-galactopyranosyl-(1->3)]-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- alpha-L-Fuc-(1->2)-[beta-D-Gal-(1->4)-alpha-D-GalNAc-(1->3)]-beta-D-Gal-(1->4)-beta-D-GlcNAc
- alpha-L-fucopyranosyl-(1->2)-[beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-alpha-D-galactopyranosyl-(1->3)]-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- alpha-L-fucosyl-(1->2)-[beta-D-galactosyl-(1->4)-N-acetyl-alpha-D-galactosaminyl-(1->3)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosamine
- alpha-L-Fucp-(1->2)-[beta-D-Galp-(1->4)-alpha-D-GalpNAc-(1->3)]-beta-D-Galp-(1->4)-beta-D-GlcpNAc
- beta-D-Gal-(1->4)-alpha-D-GalNAc-(1->3)-[alpha-L-Fuc-(1->2)]-beta-D-Gal-(1->4)-beta-D-GlcNAc
- beta-D-glucopyranose, O-6-deoxy-alpha-L-galactopyranosyl-(1->2)-O-[O-beta-D-galactopyranosyl-(1->4)-2-(acetylamino)-2-deoxy-alpha-D-galactopyranosyl-(1->3)]-O-beta-D-galactopyranosyl-(1->4)-2-(acetylamino)-2-deoxy-
- Galb1-4GalNAca1-3(Fuca1-2)Galb1-4GlcNAcb
- Galbeta1-4GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta
- WURCS=2.0/4,5,4/[a2122h-1b_1-5_2*NCC/3=O][a2112h-1b_1-5][a1221m-1a_1-5][a2112h-1a_1-5_2*NCC/3=O]/1-2-3-4-2/a4-b1_b2-c1_b3-d1_d4-e1
- Definition
- A branched amino pentasaccharide comprised of a linear chain of beta-D-galactose, N-acetyl-alpha-D-galactosamine, beta-D-galactose and N-acetyl-beta-D-glucosamine residues linked sequentially (1->4), (1->3) and (1->4), with an alpha-L-fucosyl residue linked (1->2) to the galactose residue proximal to the reducing-end N-acetylglucosamine residue.
- References
-
- GlyGen:G44738JR
- GlyTouCan:G44738JR
- PMID:19443021
- PMID:25568069
- PMID:31537530
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_role
-
Phenotype
Phenotype resulting from beta-D-Galp-(1->4)-alpha-D-GalpNAc-(1->3)-[alpha-L-Fucp-(1->2)]-beta-D-Galp-(1->4)-beta-D-GlcpNAc
Phenotype where environments contain beta-D-Galp-(1->4)-alpha-D-GalpNAc-(1->3)-[alpha-L-Fucp-(1->2)]-beta-D-Galp-(1->4)-beta-D-GlcpNAc
Phenotype modified by environments containing beta-D-Galp-(1->4)-alpha-D-GalpNAc-(1->3)-[alpha-L-Fucp-(1->2)]-beta-D-Galp-(1->4)-beta-D-GlcpNAc
Human Disease Model